Table 1 (abstract PReS24-ABS-1185). General features of the cohort
From: Proceedings of the 31st European Paediatric Rheumatology Congress: part 2
| Â | Overall (N=114) | No recurrences (N=61 pts) | Recurrences (N=53 pts) | p |
|---|---|---|---|---|
Age, years, mean (sd) | 12 (3.9) | 12 (4) | 12 (3.8) | 0.81 |
Ethnicity | Â | Â | Â | 0.03 |
 Caucasian | 74 (65%) | 34 (55%) | 40 (75%) |  |
 Non-Caucasian | 40 (35%) | 27 (45%) | 13 (25%) |  |
Diagnosis | Â | Â | Â | 0.51 |
 Idiopathic Uveitis | 46 (40%) | 22 (36%) | 24 (45%) |  |
 Juvenile idiopathic arthritis | 52 (46%) | 28 (46%) | 24 (45%) |  |
 Other | 16 (14%) | 11 (18%) | 5 (10%) |  |
Inactivity before adalimumab taper onset, weeks, mean (sd) | 163 (174) | 189 (200) | 133 (132) | 0.72 |